Your browser doesn't support javascript.
loading
Increasing Visibility of Sickle Cell Disease in Indiana: Establishing Baseline Prevalence Using Integrated Data From Multiple Sources.
Okolo, Amanda I; Jacob, Seethal A; Dixon, Brian E; Valvi, Nimish R; Janson, Isaac A; Hardesty, Brandon M.
Afiliação
  • Okolo AI; Indiana Hemophilia and Thrombosis Center, Inc, Indianapolis, IN, USA.
  • Jacob SA; Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, IN, USA.
  • Dixon BE; Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, IN, USA.
  • Valvi NR; Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA.
  • Janson IA; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, USA.
  • Hardesty BM; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, IN, USA.
Public Health Rep ; 139(2): 201-207, 2024.
Article em En | MEDLINE | ID: mdl-37232202
ABSTRACT

OBJECTIVE:

The Indiana Sickle Cell Data Collection (IN-SCDC) program aims to provide timely, reliable, and locally relevant information on the sickle cell disease (SCD) population in Indiana to inform public health interventions, research, and policy development. We describe the development of the IN-SCDC program and report the prevalence and geographic distribution of people with SCD in Indiana using an integrated data collection approach.

METHODS:

Using multiple integrated data sources and case definitions established by the Centers for Disease Control and Prevention, we classified cases of SCD in Indiana during 2015-2019. We calculated the prevalence and incidence of SCD and described characteristics of people with SCD.

RESULTS:

We identified 1695 people living with SCD in Indiana during the study period. The median age of people living with SCD was 21 years, and 1474 (87.0%) were Black or African American. Most (n = 1596, 91%) resided in metropolitan counties. The age-adjusted prevalence of SCD was 24.7 cases per 100 000 people. The prevalence of SCD among Black or African American people was 209.3 per 100 000 people. The incidence was 1 in 2608 live births overall and 1 in 446 live births among Black or African American people. Eighty-six deaths were confirmed in this population during 2015-2019.

CONCLUSIONS:

Our results establish a baseline for the IN-SCDC program. Baseline and future surveillance program efforts will help accurately inform standards of care for treatments, identify gaps in coverage and access to care, and provide guidance for legislators and community-based organizations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme Tipo de estudo: Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme Tipo de estudo: Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article